{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:39:26Z","timestamp":1785407966383,"version":"3.56.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T00:00:00Z","timestamp":1698364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Wellcome Trust under the University Of Zimbabwe College Of Health Sciences Southern Africa Consortium for Research Excellence (SACORE) grant number","award":["087537\/F\/08\/A"],"award-info":[{"award-number":["087537\/F\/08\/A"]}]},{"name":"Wellcome Trust under the University Of Zimbabwe College Of Health Sciences Southern Africa Consortium for Research Excellence (SACORE) grant number","award":["087537\/F\/08\/A"],"award-info":[{"award-number":["087537\/F\/08\/A"]}]},{"name":"Wellcome Trust under the University Of Zimbabwe College Of Health Sciences Southern Africa Consortium for Research Excellence (SACORE) grant number","award":["087537\/F\/08\/A"],"award-info":[{"award-number":["087537\/F\/08\/A"]}]},{"name":"Wellcome Trust under the University Of Zimbabwe College Of Health Sciences Southern Africa Consortium for Research Excellence (SACORE) grant number","award":["087537\/F\/08\/A"],"award-info":[{"award-number":["087537\/F\/08\/A"]}]},{"name":"Wellcome Trust under the University Of Zimbabwe College Of Health Sciences Southern Africa Consortium for Research Excellence (SACORE) grant number","award":["087537\/F\/08\/A"],"award-info":[{"award-number":["087537\/F\/08\/A"]}]},{"name":"Wellcome Trust under the University Of Zimbabwe College Of Health Sciences Southern Africa Consortium for Research Excellence (SACORE) grant number","award":["087537\/F\/08\/A"],"award-info":[{"award-number":["087537\/F\/08\/A"]}]},{"name":"Wellcome Trust under the University Of Zimbabwe College Of Health Sciences Southern Africa Consortium for Research Excellence (SACORE) grant number","award":["087537\/F\/08\/A"],"award-info":[{"award-number":["087537\/F\/08\/A"]}]},{"name":"Wellcome Trust under the University Of Zimbabwe College Of Health Sciences Southern Africa Consortium for Research Excellence (SACORE) grant number","award":["087537\/F\/08\/A"],"award-info":[{"award-number":["087537\/F\/08\/A"]}]},{"name":"The Academy of Medical Sciences Global Challenges Research Fund Networking Grant Scheme","award":["GCRFNGR2\\10499"],"award-info":[{"award-number":["GCRFNGR2\\10499"]}]},{"name":"The Academy of Medical Sciences Global Challenges Research Fund Networking Grant Scheme","award":["GCRFNGR2\\10499"],"award-info":[{"award-number":["GCRFNGR2\\10499"]}]},{"name":"The Academy of Medical Sciences Global Challenges Research Fund Networking Grant Scheme","award":["GCRFNGR2\\10499"],"award-info":[{"award-number":["GCRFNGR2\\10499"]}]},{"name":"The Academy of Medical Sciences Global Challenges Research Fund Networking Grant Scheme","award":["GCRFNGR2\\10499"],"award-info":[{"award-number":["GCRFNGR2\\10499"]}]},{"name":"The Academy of Medical Sciences Global Challenges Research Fund Networking Grant Scheme","award":["GCRFNGR2\\10499"],"award-info":[{"award-number":["GCRFNGR2\\10499"]}]},{"name":"The Academy of Medical Sciences Global Challenges Research Fund Networking Grant Scheme","award":["GCRFNGR2\\10499"],"award-info":[{"award-number":["GCRFNGR2\\10499"]}]},{"name":"The Academy of Medical Sciences Global Challenges Research Fund Networking Grant Scheme","award":["GCRFNGR2\\10499"],"award-info":[{"award-number":["GCRFNGR2\\10499"]}]},{"name":"The Academy of Medical Sciences Global Challenges Research Fund Networking Grant Scheme","award":["GCRFNGR2\\10499"],"award-info":[{"award-number":["GCRFNGR2\\10499"]}]},{"name":"The Norwegian Programme for Capacity Development in Higher Education and Research for Development under the University of Zimbabwe NORHED grant","award":["NORHED QZA-0484MWI-13\/0032"],"award-info":[{"award-number":["NORHED QZA-0484MWI-13\/0032"]}]},{"name":"The Norwegian Programme for Capacity Development in Higher Education and Research for Development under the University of Zimbabwe NORHED grant","award":["NORHED QZA-0484MWI-13\/0032"],"award-info":[{"award-number":["NORHED QZA-0484MWI-13\/0032"]}]},{"name":"The Norwegian Programme for Capacity Development in Higher Education and Research for Development under the University of Zimbabwe NORHED grant","award":["NORHED QZA-0484MWI-13\/0032"],"award-info":[{"award-number":["NORHED QZA-0484MWI-13\/0032"]}]},{"name":"The Norwegian Programme for Capacity Development in Higher Education and Research for Development under the University of Zimbabwe NORHED grant","award":["NORHED QZA-0484MWI-13\/0032"],"award-info":[{"award-number":["NORHED QZA-0484MWI-13\/0032"]}]},{"name":"The Norwegian Programme for Capacity Development in Higher Education and Research for Development under the University of Zimbabwe NORHED grant","award":["NORHED QZA-0484MWI-13\/0032"],"award-info":[{"award-number":["NORHED QZA-0484MWI-13\/0032"]}]},{"name":"The Norwegian Programme for Capacity Development in Higher Education and Research for Development under the University of Zimbabwe NORHED grant","award":["NORHED QZA-0484MWI-13\/0032"],"award-info":[{"award-number":["NORHED QZA-0484MWI-13\/0032"]}]},{"name":"The Norwegian Programme for Capacity Development in Higher Education and Research for Development under the University of Zimbabwe NORHED grant","award":["NORHED QZA-0484MWI-13\/0032"],"award-info":[{"award-number":["NORHED QZA-0484MWI-13\/0032"]}]},{"name":"The Norwegian Programme for Capacity Development in Higher Education and Research for Development under the University of Zimbabwe NORHED grant","award":["NORHED QZA-0484MWI-13\/0032"],"award-info":[{"award-number":["NORHED QZA-0484MWI-13\/0032"]}]},{"name":"The Botnar Foundation and the Department of Visceral Surgery and Medicine, Bern University, Switzerland","award":["001"],"award-info":[{"award-number":["001"]}]},{"name":"The Botnar Foundation and the Department of Visceral Surgery and Medicine, Bern University, Switzerland","award":["001"],"award-info":[{"award-number":["001"]}]},{"name":"The Botnar Foundation and the Department of Visceral Surgery and Medicine, Bern University, Switzerland","award":["001"],"award-info":[{"award-number":["001"]}]},{"name":"The Botnar Foundation and the Department of Visceral Surgery and Medicine, Bern University, Switzerland","award":["001"],"award-info":[{"award-number":["001"]}]},{"name":"The Botnar Foundation and the Department of Visceral Surgery and Medicine, Bern University, Switzerland","award":["001"],"award-info":[{"award-number":["001"]}]},{"name":"The Botnar Foundation and the Department of Visceral Surgery and Medicine, Bern University, Switzerland","award":["001"],"award-info":[{"award-number":["001"]}]},{"name":"The Botnar Foundation and the Department of Visceral Surgery and Medicine, Bern University, Switzerland","award":["001"],"award-info":[{"award-number":["001"]}]},{"name":"The Botnar Foundation and the Department of Visceral Surgery and Medicine, Bern University, Switzerland","award":["001"],"award-info":[{"award-number":["001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Despite the availability of an effective vaccine, chronic hepatitis B virus (HBV) infections remain a major cause of liver cirrhosis and hepatocellular carcinoma. HBV burden in pregnancy, risk factors and the timing of mother to child transmission remain poorly described especially during this era of lifelong use of Tenofovir\/Lamivudine\/Efavirenz as firstline for HIV treatment. We aimed to determine the burden\u00a0of HBV in pregnancy and infants receiving their first dose of HBV\u00a0vaccine 6\u00a0weeks after birth in a high HIV-prevalence setting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Pregnant women\u2009\u2265\u200920\u00a0weeks\u2019 gestational age were enrolled\u00a0and followed\u00a0up as mother-infant\u00a0dyads from delivery, 6, 24 and 96\u00a0weeks after birth. HBV\u00a0surface\u00a0antigen (HBsAg) was tested (fresh plasma, immunochromatography) in pregnancy. Women testing HBsAg-seropositive were further evaluated for other four HBV-biomarkers. Maternally HBV\u00a0exposed\u00a0babies were tested for HBsAg from birth and HBs-antibodies from 6\u00a0months of age. Maternal-infant factors were tested in univariable and multivariable analyses for predictors of HBsAg-seropositivity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p> Six hundred\u00a0HIV-uninfected and 608 HIV-infected women on Tenofovir\/Lamivudine\/Efavirenz-regimen with median (interquartile range) 350:\u00a0(87\u20131477) days of therapy use were enrolled. The overall HBsAg-seroprevalence was 32\/1208:\u00a02.65%, 95% confidence\u00a0interval (CI) [1.74, 3.55]; being 7\/600:\u00a01.17%, 95% CI\u00a0[0.37, 1.97] and 25\/608:\u00a04.11%, 95% CI\u00a0[2.52, 5.68] in HBsAg-monoinfected and HBsAg\/HIV-coinfected respectively, disproportionately detected in 31\/32:\u00a096.9%, 95% CI\u00a0[90.8, 100] women presumably HBV-unvaccinated in infancy.<\/jats:p>\n                <jats:p>HBV\u00a0exposed\u00a0babies tended to be born prematurely (&lt;\u200937\u00a0weeks); 15.2% versus 9.9% in the HBV-unexposed, <jats:italic>p<\/jats:italic>\u2009=\u20090.009.<\/jats:p>\n                <jats:p>In multivariate\u00a0logistic\u00a0regression-models with variable\u00a0elimination, HIV-infection and reported\u00a0tooth\u00a0extractions predicted antenatal HBsAg-seropositivity; odds ratios (CI):\u00a03.85 (1.61\u201310.7) and 2.46 (1.07\u20135.34), respectively.<\/jats:p>\n                <jats:p>None of the exposed\u00a0infants were HBsAg-seropositive neither before nor after 6 weeks\u00a0of age. No HBs-antibodies were detected in 23.3% of HBsAg-exposed infants at two years despite having successfully completed the HBV vaccination schedule.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Low and moderate HBV endemics were observed in HIV-uninfected and HIV-infected pregnant women, respectively. This underscores the need to routinely screen for HBV in pregnancy, especially the HIV-infected attending antenatal-care. Being HIV-infected and reported\u00a0tooth\u00a0extractions were independent\u00a0risk\u00a0factors for maternal HBsAg-seropositivity. Vertical and child\u00a0horizontal transmissions were both absent, probably due to\u2009~\u2009the\u00a050% frequency of antenatal anti-HBe-antibodies observed. Of concern was the absence of anti-HBs-antibodies in 23.3% of fully\u00a0vaccinated\/maternally\u00a0HBV-exposed\u00a0infants by two years. Absence of molecular diagnosis may have underestimated HBV burden.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.clinicaltrials.gov\">www.clinicaltrials.gov<\/jats:ext-link>, trial registration number: NCT04087239.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08523-2","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T14:03:30Z","timestamp":1698415410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24\u00a0months after birth in a high HIV prevalence setting"],"prefix":"10.1186","volume":"23","author":[{"given":"Kerina","family":"Duri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Privilege Tendai","family":"Munjoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope","family":"Mataramvura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur John","family":"Mazhandu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panashe","family":"Chandiwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarisai","family":"Marere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicity Zvanyadza","family":"Gumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovemore Ronald","family":"Mazengera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"issue":"9","key":"8523_CR1","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.mayocp.2016.06.009","volume":"91","author":"R Rajbhandari","year":"2016","unstructured":"Rajbhandari R, Simon RE, Chung RT, Ananthakrishnan AN. Racial disparities in inhospital outcomes for hepatocellular carcinoma in the United States. Mayo Clin Proc. 2016;91(9):1173\u201382.","journal-title":"Mayo Clin Proc"},{"issue":"10161","key":"8523_CR2","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1016\/S0140-6736(18)31865-8","volume":"392","author":"WK Seto","year":"2018","unstructured":"Seto WK, Lo YR, Pawlotsky JM, Yuen MF. Chronic hepatitis B virus infection. Lancet. 2018;392(10161):2313\u201324.","journal-title":"Lancet"},{"issue":"2","key":"8523_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/15284336.2016.1276312","volume":"18","author":"M Floridia","year":"2017","unstructured":"Floridia M, Masuelli G, Tamburrini E, Spinillo A, Simonazzi G, Guaraldi G, et al. HBV coinfection is associated with reduced CD4 response to antiretroviral treatment in pregnancy. HIV Clin Trials. 2017;18(2):54\u20139.","journal-title":"HIV Clin Trials"},{"issue":"7","key":"8523_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134037","volume":"10","author":"PC Matthews","year":"2015","unstructured":"Matthews PC, Beloukas A, Malik A, Carlson JM, Jooste P, Ogwu A, et al. Prevalence and characteristics of hepatitis B Virus (HBV) Coinfection among HIV-positive women in South Africa and Botswana. PLoS ONE. 2015;10(7): e0134037.","journal-title":"PLoS ONE"},{"issue":"3","key":"8523_CR5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/jvh.13217","volume":"27","author":"L Platt","year":"2020","unstructured":"Platt L, French CE, McGowan CR, Sabin K, Gower E, Trickey A, et al. Prevalence and burden of HBV co-infection among people living with HIV: a global systematic review and meta-analysis. J Viral Hepat. 2020;27(3):294\u2013315.","journal-title":"J Viral Hepat"},{"key":"8523_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijid.2014.07.018","volume":"28","author":"R Yang","year":"2014","unstructured":"Yang R, Gui X, Xiong Y, Gao SC, Yan Y. Impact of hepatitis B virus infection on HIV response to antiretroviral therapy in a Chinese antiretroviral therapy center. Int J Infect Dis. 2014;28:29\u201334.","journal-title":"Int J Infect Dis"},{"issue":"Suppl 3","key":"8523_CR7","first-page":"17","volume":"27","author":"L Breakwell","year":"2017","unstructured":"Breakwell L, Tevi-Benissan C, Childs L, Mihigo R, Tohme R. The status of hepatitis B control in the African region. Pan Afr Med J. 2017;27(Suppl 3):17.","journal-title":"Pan Afr Med J"},{"issue":"7","key":"8523_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181267","volume":"12","author":"N Chotun","year":"2017","unstructured":"Chotun N, Preiser W, van Rensburg CJ, Fernandez P, Theron GB, Glebe D, et al. Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic: A South African experience. PLoS ONE. 2017;12(7): e0181267.","journal-title":"PLoS ONE"},{"issue":"Suppl 2","key":"8523_CR9","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1136\/gut.38.Suppl_2.S5","volume":"38","author":"CF Kiire","year":"1996","unstructured":"Kiire CF. The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa. Gut. 1996;38(Suppl 2):S5-12.","journal-title":"Gut"},{"issue":"10003","key":"8523_CR10","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546\u201355.","journal-title":"Lancet"},{"key":"8523_CR11","unstructured":"World Health Organisation. Hepatitis b. 2022; https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"key":"8523_CR12","unstructured":"Zimbabwe National Statistics Agency and ICF International. Zimbabwe Demographic and Health Survey 2015: Final Report. Rockville: Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International; 2016."},{"issue":"8","key":"8523_CR13","first-page":"195","volume":"45","author":"S Madzime","year":"1999","unstructured":"Madzime S, Adem M, Mahomed K, Woelk GB, Mudzamiri S, Williams MA. Hepatitis B virus infection among pregnant women delivering at Harare Maternity Hospital, Harare Zimbabwe, 1996 to 1997. Cent Afr J Med. 1999;45(8):195\u20138.","journal-title":"Cent Afr J Med"},{"issue":"1","key":"8523_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejogrb.2010.02.021","volume":"150","author":"RT Mavenyengwa","year":"2010","unstructured":"Mavenyengwa RT, Moyo SR, Nordbo SA. Streptococcus agalactiae colonization and correlation with HIV-1 and HBV seroprevalence in pregnant women from Zimbabwe. Eur J Obstet Gynecol Reprod Biol. 2010;150(1):34\u20138.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"8523_CR15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1186\/s12879-020-05432-6","volume":"20","author":"K Duri","year":"2020","unstructured":"Duri K, Gumbo FZ, Munjoma PT, Chandiwana P, Mhandire K, Ziruma A, et al. The University of Zimbabwe College of Health Sciences (UZ-CHS) BIRTH COHORT study: rationale, design and methods. BMC Infect Dis. 2020;20(1):725.","journal-title":"BMC Infect Dis"},{"key":"8523_CR16","doi-asserted-by":"publisher","first-page":"838234","DOI":"10.3389\/fviro.2022.838234","volume":"2","author":"K Duri","year":"2022","unstructured":"Duri K, Munjoma PT, Mazhandu AJ, Marere T, Gomo E, Banhwa S, et al. Predictors and timing to viral suppression in HIV-infected pregnant women in the University of Zimbabwe Birth Cohort Study during the era of lifelong antiretroviral therapy (Option B+ treatment strategy). Front Virol. 2022;2:838234.","journal-title":"Front. Virol."},{"key":"8523_CR17","doi-asserted-by":"publisher","first-page":"906271","DOI":"10.3389\/fviro.2022.906271","volume":"2","author":"K Duri","year":"2022","unstructured":"Duri K, Mataramvura H, Chandiwana P, Mazhandu AJ, Banhwa S, Munjoma PT, et al. Mother to child transmission of HIV within 24 months after delivery in women initiating lifelong antiretroviral therapy pre-\/-post-conception or postnatally; effects of adolescent girl and young woman status and plasma viremia late in pregnancy. Front Virol. 2022;2:906271.","journal-title":"Front Virol"},{"issue":"6","key":"8523_CR18","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","volume":"19","author":"H Akaike","year":"1974","unstructured":"Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974;19(6):716\u201323.","journal-title":"IEEE Trans Autom Control"},{"issue":"1","key":"8523_CR19","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1186\/s12879-017-2714-0","volume":"17","author":"M Mutagoma","year":"2017","unstructured":"Mutagoma M, Balisanga H, Malamba SS, Sebuhoro D, Remera E, Riedel DJ, et al. Hepatitis B virus and HIV co-infection among pregnant women in Rwanda. BMC Infect Dis. 2017;17(1):618.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"8523_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2471\/BLT.20.281311","volume":"100","author":"A Loarec","year":"2022","unstructured":"Loarec A, Nguyen A, Molfino L, Chissano M, Madeira N, Rusch B, et al. Prevention of mother-to-child transmission of hepatitis B virus in antenatal care and maternity services Mozambique. Bull World Health Organ. 2022;100(1):60\u20139.","journal-title":"Bull World Health Organ"},{"key":"8523_CR21","first-page":"61","volume":"41","author":"ARN Mawouma","year":"2022","unstructured":"Mawouma ARN, Djoulatou AH, Komnang EO, Kimessoukie EO. Factors associated with hepatitis B infection in pregnant women at health facilities in the health district of Mokolo\/Far North of Cameroon. Pan Afr Med J. 2022;41:61.","journal-title":"Pan Afr Med J"},{"issue":"10","key":"8523_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259218","volume":"16","author":"BO Olakunde","year":"2021","unstructured":"Olakunde BO, Adeyinka DA, Olakunde OA, Uthman OA, Bada FO, Nartey YA, et al. A systematic review and meta-analysis of the prevalence of hepatitis B virus infection among pregnant women in Nigeria. PLoS ONE. 2021;16(10): e0259218.","journal-title":"PLoS ONE"},{"key":"8523_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ijid.2020.09.1459","volume":"102","author":"GA Yendewa","year":"2021","unstructured":"Yendewa GA, Lakoh S, Yendewa SA, Bangura K, Lawrence H, Patino L, et al. Prevalence of hepatitis B surface antigen and serological markers of other endemic infections in HIV-infected children, adolescents and pregnant women in Sierra Leone: A cross-sectional study. Int J Infect Dis. 2021;102:45\u201352.","journal-title":"Int J Infect Dis"},{"issue":"11","key":"8523_CR24","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/jvh.12735","volume":"24","author":"HS Kim","year":"2017","unstructured":"Kim HS, Rotundo L, Yang JD, Kim D, Kothari N, Feurdean M, et al. Racial\/ethnic disparities in the prevalence and awareness of Hepatitis B virus infection and immunity in the United States. J Viral Hepat. 2017;24(11):1052\u201366.","journal-title":"J Viral Hepat"},{"issue":"1","key":"8523_CR25","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12985-020-01443-6","volume":"17","author":"HM Kafeero","year":"2020","unstructured":"Kafeero HM, Ndagire D, Ocama P, Walusansa A, Sendagire H. Sero-prevalence of human immunodeficiency virus-hepatitis B virus (HIV-HBV) co-infection among pregnant women attending antenatal care (ANC) in sub-Saharan Africa (SSA) and the associated risk factors: a systematic review and meta-analysis. Virol J. 2020;17(1):170.","journal-title":"Virol J"},{"issue":"2","key":"8523_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/jmv.24641","volume":"89","author":"I Baudi","year":"2017","unstructured":"Baudi I, Iijima S, Chin\u2019ombe N, Mtapuri-Zinyowera S, Murakami S, Isogawa M, et al. Molecular epidemiology of co-infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare. Zimbabwe J Med Virol. 2017;89(2):257\u201366.","journal-title":"Zimbabwe J Med Virol"},{"issue":"9\u201312","key":"8523_CR27","first-page":"56","volume":"60","author":"P Kurira","year":"2014","unstructured":"Kurira P, Ndhlovu CE, Gomo ZA. Hepatitis B and C infection at a large public sector hospital clinic: is it a burden? Cent Afr J Med. 2014;60(9\u201312):56\u201362.","journal-title":"Cent Afr J Med"},{"issue":"8","key":"8523_CR28","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1097\/QAD.0000000000001454","volume":"31","author":"H Price","year":"2017","unstructured":"Price H, Dunn D, Zachary T, Vudriko T, Chirara M, Kityo C, et al. Hepatitis B serological markers and plasma DNA concentrations. AIDS. 2017;31(8):1109\u201317.","journal-title":"AIDS"},{"issue":"3","key":"8523_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.5588\/pha.20.0008","volume":"10","author":"TP Goverwa-Sibanda","year":"2020","unstructured":"Goverwa-Sibanda TP, Mupanguri C, Timire C, Harries AD, Ngwenya S, Chikwati E, et al. Hepatitis B infection in people living with HIV who initiate antiretroviral therapy in Zimbabwe. Public Health Action. 2020;10(3):97\u2013103.","journal-title":"Public Health Action"},{"issue":"1","key":"8523_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/157016211794582623","volume":"9","author":"JA Mata Marin","year":"2011","unstructured":"Mata Marin JA, Martinez JG, Flores RA, Alvarez SM, de Jesus AM. I. Aminotransferase serum levels decrease after initiating antiretroviral treatment in HIV infected patients. Curr HIV Res. 2011;9(1):23\u20137.","journal-title":"Curr HIV Res"},{"key":"8523_CR31","doi-asserted-by":"publisher","first-page":"8435019","DOI":"10.1155\/2019\/8435019","volume":"2019","author":"M Bierhoff","year":"2019","unstructured":"Bierhoff M, Angkurawaranon C, Myat MA, Gilder ME, Win TN, Keereevijitt A, et al. Maternal hepatitis B infection burden, comorbidity and pregnancy outcome in a low-income population on the Myanmar-Thailand border: a retrospective cohort study. J Pregnancy. 2019;2019:8435019.","journal-title":"J Pregnancy"},{"issue":"9","key":"8523_CR32","doi-asserted-by":"publisher","first-page":"489","DOI":"10.5694\/j.1326-5377.2009.tb02524.x","volume":"190","author":"E Wiseman","year":"2009","unstructured":"Wiseman E, Fraser MA, Holden S, Glass A, Kidson BL, Heron LG, et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust. 2009;190(9):489\u201392.","journal-title":"Med J Aust"},{"issue":"26","key":"8523_CR33","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.3748\/wjg.v13.i26.3625","volume":"13","author":"H Bai","year":"2007","unstructured":"Bai H, Zhang L, Ma L, Dou XG, Feng GH, Zhao GZ. Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra-uterine transmission mechanism. World J Gastroenterol. 2007;13(26):3625\u201330.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"8523_CR34","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/jvh.12032","volume":"20","author":"Z Guo","year":"2013","unstructured":"Guo Z, Shi XH, Feng YL, Wang B, Feng LP, Wang SP, et al. Risk factors of HBV intrauterine transmission among HBsAg-positive pregnant women. J Viral Hepat. 2013;20(5):317\u201321.","journal-title":"J Viral Hepat"},{"key":"8523_CR35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/epirev\/mxj009","volume":"28","author":"CW Shepard","year":"2006","unstructured":"Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006;28:112\u201325.","journal-title":"Epidemiol Rev"},{"issue":"23","key":"8523_CR36","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.3748\/wjg.v11.i23.3582","volume":"11","author":"JS Wang","year":"2005","unstructured":"Wang JS, Chen H, Zhu QR. Transformation of hepatitis B serologic markers in babies born to hepatitis B surface antigen positive mothers. World J Gastroenterol. 2005;11(23):3582\u20135.","journal-title":"World J Gastroenterol"},{"key":"8523_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/1743-422X-8-227","volume":"8","author":"S Sun","year":"2011","unstructured":"Sun S, Meng S, Zhang R, Zhang K, Wang L, Li J. Development of a new duplex real-time polymerase chain reaction assay for hepatitis B viral DNA detection. Virol J. 2011;8:227.","journal-title":"Virol J"},{"issue":"4","key":"8523_CR38","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ijid.2008.08.018","volume":"13","author":"C Firnhaber","year":"2009","unstructured":"Firnhaber C, Viana R, Reyneke A, Schultze D, Malope B, Maskew M, et al. Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg. South Africa Int J Infect Dis. 2009;13(4):488\u201392.","journal-title":"South Africa Int J Infect Dis"},{"issue":"1","key":"8523_CR39","doi-asserted-by":"publisher","first-page":"e0190592","DOI":"10.1371\/journal.pone.0190592","volume":"13","author":"B Bivigou-Mboumba","year":"2018","unstructured":"Bivigou-Mboumba B, Amougou-Atsama M, Zoa-Assoumou S, M\u2019boyis KH, Nzengui-Nzengui GF, Ndojyi-Mbiguino A, et al. Hepatitis B infection among HIV infected individuals in Gabon: occult hepatitis B enhances HBV DNA prevalence. PLoS One. 2018;13(1):e0190592.","journal-title":"PLoS One"},{"issue":"46","key":"8523_CR40","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1016\/j.vaccine.2013.09.026","volume":"31","author":"B Yucesoy","year":"2013","unstructured":"Yucesoy B, Talzhanov Y, Johnson VJ, Wilson NW, Biagini RE, Wang W, et al. Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations. Vaccine. 2013;31(46):5381\u201391.","journal-title":"Vaccine"},{"issue":"2","key":"8523_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149199","volume":"11","author":"B Xie","year":"2016","unstructured":"Xie B, Zhang P, Liu M, Zeng W, Yang J, Liu H. Deltex1 polymorphisms are associated with hepatitis B vaccination non-response in Southwest China. PLoS ONE. 2016;11(2): e0149199.","journal-title":"PLoS ONE"},{"issue":"39","key":"8523_CR42","doi-asserted-by":"publisher","first-page":"5708","DOI":"10.1016\/j.vaccine.2012.07.010","volume":"30","author":"Y Wang","year":"2012","unstructured":"Wang Y, Xu P, Zhu D, Zhang S, Bi Y, Hu Y, et al. Association of polymorphisms of cytokine and TLR-2 genes with long-term immunity to hepatitis B in children vaccinated early in life. Vaccine. 2012;30(39):5708\u201313.","journal-title":"Vaccine"},{"issue":"8","key":"8523_CR43","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1093\/hmg\/ddt586","volume":"23","author":"L Pan","year":"2014","unstructured":"Pan L, Zhang L, Zhang W, Wu X, Li Y, Yan B, et al. A genome-wide association study identifies polymorphisms in the HLA-DR region associated with non-response to hepatitis B vaccination in Chinese Han populations. Hum Mol Genet. 2014;23(8):2210\u20139.","journal-title":"Hum Mol Genet"},{"issue":"17","key":"8523_CR44","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.3748\/wjg.v22.i17.4287","volume":"22","author":"H Kim","year":"2016","unstructured":"Kim H, Lee SA, Do SY, Kim BJ. Precore\/core region mutations of hepatitis B virus related to clinical severity. World J Gastroenterol. 2016;22(17):4287\u201396.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"8523_CR45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1089\/vim.2015.0073","volume":"29","author":"F He","year":"2016","unstructured":"He F, Ma YJ, Zhou TY, Duan JC, Wang JF, Ji YL, et al. The serum anti-HBs level among children who received routine hepatitis B vaccination during infancy in Mianyang City, China: a cross-sectional study. Viral Immunol. 2016;29(1):40\u20138.","journal-title":"Viral Immunol"},{"issue":"40","key":"8523_CR46","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1016\/j.vaccine.2016.08.027","volume":"34","author":"W Fan","year":"2016","unstructured":"Fan W, Chen XF, Shen C, Guo ZR, Dong C. Hepatitis B vaccine response in obesity: a meta-analysis. Vaccine. 2016;34(40):4835\u201341.","journal-title":"Vaccine"},{"issue":"7","key":"8523_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011680","volume":"6","author":"M Voysey","year":"2016","unstructured":"Voysey M, Pollard AJ, Perera R, Fanshawe TR. Assessing sex-differences and the effect of timing of vaccination on immunogenicity, reactogenicity and efficacy of vaccines in young children: study protocol for an individual participant data meta-analysis of randomised controlled trials. BMJ Open. 2016;6(7): e011680.","journal-title":"BMJ Open"},{"issue":"10","key":"8523_CR48","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/jvh.12543","volume":"23","author":"A Katoonizadeh","year":"2016","unstructured":"Katoonizadeh A, Sharafkhah M, Ostovaneh MR, Norouzi A, Khoshbakht N, Mohamadkhani A, et al. Immune responses to hepatitis B immunization 10\u201318 years after primary vaccination: a population-based cohort study. J Viral Hepat. 2016;23(10):805\u201311.","journal-title":"J Viral Hepat"},{"issue":"8","key":"8523_CR49","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.37786","volume":"16","author":"J Fan","year":"2016","unstructured":"Fan J, Huang X, Chen J, Cai Y, Xiong L, Mu L, et al. Host genetic variants in HLA Loci influence risk for hepatitis B virus infection in children. Hepat Mon. 2016;16(8): e37786.","journal-title":"Hepat Mon"},{"key":"8523_CR50","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.clinre.2016.04.005","volume":"40","author":"X Liu","year":"2016","unstructured":"Liu X, Yu L, Han C, Lu S, Zhu G, Su H, et al. Polymorphisms of HLA-DQB1 predict survival of hepatitis B virus-related hepatocellular carcinoma patients receiving hepatic resection. Clin Res Hepatol Gastroenterol. 2016;40:739.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"9","key":"8523_CR51","doi-asserted-by":"publisher","first-page":"12103","DOI":"10.1007\/s13277-016-5077-z","volume":"37","author":"X Gao","year":"2016","unstructured":"Gao X, Liu W, Zhang X, Tang L, Wang L, Yan L, et al. Genetic polymorphism of HLA-DQ confers susceptibility to hepatitis B virus-related hepatocellular carcinoma: a case-control study in Han population in China. Tumour Biol. 2016;37(9):12103\u201311.","journal-title":"Tumour Biol"},{"issue":"3","key":"8523_CR52","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.cld.2010.05.012","volume":"14","author":"KM Chang","year":"2010","unstructured":"Chang KM. Hepatitis B immunology for clinicians. Clin Liver Dis. 2010;14(3):409\u201324.","journal-title":"Clin Liver Dis"},{"issue":"9","key":"8523_CR53","doi-asserted-by":"publisher","first-page":"628","DOI":"10.7196\/SAMJ.7952","volume":"104","author":"A Buchner","year":"2014","unstructured":"Buchner A, Omar FE, Vermeulen J, Reynders DT. Investigating hepatitis B immunity in patients presenting to a paediatric haematology and oncology unit in South Africa. S Afr Med J. 2014;104(9):628\u201331.","journal-title":"S Afr Med J"},{"key":"8523_CR54","doi-asserted-by":"publisher","first-page":"18871","DOI":"10.7448\/IAS.17.1.18871","volume":"17","author":"CJ Hoffmann","year":"2014","unstructured":"Hoffmann CJ, Mashabela F, Cohn S, Hoffmann JD, Lala S, Martinson NA, et al. Maternal hepatitis B and infant infection among pregnant women living with HIV in South Africa. J Int AIDS Soc. 2014;17:18871.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"8523_CR55","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/s12879-016-1754-1","volume":"16","author":"L Zhang","year":"2016","unstructured":"Zhang L, Gui XE, Wang B, Fan JY, Cao Q, Mullane K, et al. Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates. BMC Infect Dis. 2016;16(1):408.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08523-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08523-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08523-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T14:06:58Z","timestamp":1698415618000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08523-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,27]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8523"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08523-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,27]]},"assertion":[{"value":"5 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"UZBCS complied with the ethical principles of the Declaration of Helsinki and was conducted in compliance with the international council for harmonisation of Good Clinical and Laboratory Practice guidelines and local regulatory requirements. Ethical approval was obtained from the Joint Research Ethics Committee (JREC) of the University of Zimbabwe and Parirenyatwa Group of Hospitals reference number; JREC\/18\/15 and the Medical Research Council of Zimbabwe; MRCZ\/A\/1968. Literacy is nearly universal in Zimbabwe and all potential participants were able to read and comprehend the informed consent form. All study participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"736"}}